Sahpra News Updates

Pretoria, 17 January 2025 – The South African Health Products Regulatory Authority (SAHPRA) has recommended that the product information ofmedroxyprogesterone acetate (MPA)-containing products be amended by updating the safety warnings to include the potential risk of meningioma. MPA is a synthetic oral and injectable form... The post SAHPRA clarifies the… Read more »

The South African Health Products Regulatory Authority (SAHPRA) wishes to inform stakeholders that the organisation’s telephone system has been restored. SAHPRA apologises for any inconvenience this may have caused. The post Telephone system has been restored appeared first on SAHPRA. Read more »

The South African Health Products Regulatory Authority (SAHPRA) wishes to inform stakeholders that the organisation is currently experiencing a technical issue with its telephone system, which is affecting both outgoing and incoming calls. The Authority’s service provider is working diligently to resolve the issue as... The post Temporary telephone system… Read more »

Please note that SAHPRA Head Office, including Cape Town and Durban Regional Offices will be unavilable today, 29 November 2024 due to the organisation’s Annual General Meeting. If you require assistance, please use applicable contacts from Key Contacts: https://www.sahpra.org.za/key-contacts/ The post SAHPRA Offices will be unavailable on 29 November 2024… Read more »

SAHPRA offices will be closed for the festive season from 12:00 on Tuesday, 24 December 2024 and will re-open on Monday, 06 January 2025. Please note: Submissions to SAHPRA New Medicine, Variation, License, Renewal Applications Applications/submissions via sFTP will continue however applications received after 20... The post SAHPRA office closure… Read more »

Pretoria, 21 November 2024 – The South African Health Products Regulatory Authority (SAHPRA) is aware of a quality issue in a batch of YAZ Plus contraceptives (Batch No. WEW96J distributed on 09 and 24 November 2023) which has resulted in the incorrect arrangement of tablets... The post SAHPRA recalls a… Read more »

Pretoria, 08 November 2024 –The South African Health Products Regulatory Authority (SAHPRA) is concerned about the proliferation of falsified, compounded and substandard Glucagon-like Peptide (GLP-1)-containing products being made available to the public via websites, social media platforms and other informal channels. These pose a health... The post SAHPRA’s position on… Read more »

Pretoria, 07 November 2024 – The South African Health Products Regulatory Authority (SAHPRA) encourages members of the public to always report any suspected side effects they may experience from taking medicines, vaccines and/or using medical devices, to help make medicines safer for everyone.  While humanity... The post SAHPRA encourages the… Read more »

Pretoria, 18 October 2024 – On the 25th and 26th of September 2024, the School of Physical and Chemical Sciences (SPCS) at North-West University’s Mafikeng Campus hosted a vibrant and educational “SPCS in Action” event. This two-day event gathered leading organisations in chemistry, biochemistry, and... The post North-West University Hosts… Read more »

Pretoria, South Africa and Canberra, Australia, 07 October 2024 –The South African Health Products Regulatory Authority (SAHPRA) and the Australian Therapeutic Goods Administration (TGA) have signed a Memorandum of Understanding (MoU), which will strengthen collaboration between the two health product regulators. The MoU builds on... The post South African and… Read more »